.Merck trumps revenues desires, raises sales expectation on sturdy demand for best drugs like Keytruda CNBCMerck & Co. (MRK US) Defeats Earnings Forecasts as Keytruda Purchases Growth BloombergMerck Supply: Pharma Giant Posts Powerful Results, But Expectation Tumbles Short Capitalist's Service DailyMerck Announces Second-Quarter 2024 Financial End results Yahoo FinanceMerck beats earnings and also sales requirements among Keytruda advantage, however delivers combined full-year expectation MarketWatch.